Hypereosinophilic syndrome and mepolizumab

New England Journal of Medicine

Volumn 358, Issue 26, 2008, Pages 2839-

  Boulware, David R ^a   Stauffer III, William M ^a   Walker, Patricia F ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEPOLIZUMAB; MONOCLONAL ANTIBODY;

DRUG SAFETY; HYPEREOSINOPHILIC SYNDROME; IMMIGRANT; INFECTION RISK; LETTER; PARASITOSIS; PRIORITY JOURNAL; STRONGYLOIDES STERCORALIS; ANIMAL; DRUG EFFECT; EOSINOPHIL; HUMAN; NOTE; STRONGYLOIDIASIS;

ANIMALS; ANTIBODIES, MONOCLONAL; EOSINOPHILS; HUMANS; HYPEREOSINOPHILIC SYNDROME; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 45949110896     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Newberry AM, Williams DN, Stauffer WM, Boulware DR, Hendel-Paterson BR, Walker PF. Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest 2005;128:3681-4.
2. Seybolt LM, Christiansen D, Barnett ED. Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis 2006;42:363-7.
3. Posey DL, Blackburn BG, Weinberg M, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis 2007;45:1310-5.
4. Boulware DR, Stauffer WM III, Hendel-Patterson BR, et al. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med 2007;120:545-51.
5. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002;66:749-52.